These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24941131)

  • 1. Comparison of patients from Nigeria and the USA highlights modifiable risk factors for sickle cell anemia complications.
    Akingbola TS; Tayo BO; Salako B; Layden JE; Hsu LL; Cooper RS; Gordeuk VR; Saraf SL
    Hemoglobin; 2014; 38(4):236-43. PubMed ID: 24941131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial Doppler screening in Nigerian children with sickle cell disease: A 10-year longitudinal study on the SPPIBA cohort.
    Lagunju IA; Labaeka A; Ibeh JN; Orimadegun AE; Brown BJ; Sodeinde OO
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28906. PubMed ID: 33522690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke recurrence in Nigerian children with sickle cell disease treated with hydroxyurea.
    Lagunju IA; Brown BJ; Sodeinde OO
    Niger Postgrad Med J; 2013 Sep; 20(3):181-7. PubMed ID: 24287747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.
    Galadanci AA; Galadanci NA; Jibir BW; Abdullahi SU; Idris N; Gambo S; Ali Abubakar SA; Kabo NA; Bello-Manga H; Haliru L; Bashir I; Aliyu MH; Galadanci JA; DeBaun MR
    Am J Hematol; 2019 Nov; 94(11):E305-E307. PubMed ID: 31423630
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-invasive estimation of pulmonary artery pressures in patients with sickle cell anaemia in Ibadan, Nigeria: an echocardiographic study.
    Enakpene EO; Adebiyi AA; Ogah OS; Olaniyi JA; Aje A; Adeoye MA; Falase AO
    Acta Cardiol; 2014 Oct; 69(5):505-11. PubMed ID: 25638838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse neurological outcomes in Nigerian children with sickle cell disease.
    Lagunju IA; Brown BJ
    Int J Hematol; 2012 Dec; 96(6):710-8. PubMed ID: 23129067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual stroke incidence in Nigerian children with sickle cell disease and elevated TCD velocities treated with hydroxyurea.
    Lagunju I; Brown BJ; Oyinlade AO; Asinobi A; Ibeh J; Esione A; Sodeinde OO
    Pediatr Blood Cancer; 2019 Mar; 66(3):e27252. PubMed ID: 29797633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort.
    Lagunju I; Brown BJ; Sodeinde O
    Pediatr Blood Cancer; 2015 Sep; 62(9):1587-91. PubMed ID: 25847050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).
    Galadanci NA; Umar Abdullahi S; Vance LD; Musa Tabari A; Ali S; Belonwu R; Salihu A; Amal Galadanci A; Wudil Jibir B; Bello-Manga H; Neville K; Kirkham FJ; Shyr Y; Phillips S; Covert BV; Kassim AA; Jordan LC; Aliyu MH; DeBaun MR
    Am J Hematol; 2017 Aug; 92(8):780-788. PubMed ID: 28439953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to the use of hydroxyurea in the management of sickle cell disease in Nigeria.
    Adeyemo TA; Diaku-Akinwunmi IN; Ojewunmi OO; Bolarinwa AB; Adekile AD
    Hemoglobin; 2019 May; 43(3):188-192. PubMed ID: 31462098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke prevalence amongst sickle cell disease patients in Nigeria: a multi-centre study.
    Jude MA; Aliyu GN; Nalado AM; Garba KU; Florence FO; Hassan A; Inyama M; Akinpelu O; Theresa N; Godswill IO; Sunday O; Ifeoma E; Anthony I; Batholomew C; Chide OE; Joseph O; Malachy I; Korubo K; Sabastine AU; Kingsley A; Nonyelu C; Ugwu A; Duru A; Anigbo C; Eze A; Chukwurah A; Ololo U; Omoti C; Agwu O; Iheanyi O
    Afr Health Sci; 2014 Jun; 14(2):446-52. PubMed ID: 25320596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the morbidity associated with sickle cell anemia among patients in Ibadan (Nigeria) and Oakland (U.S.A.).
    Oyejide OC; Adeyokunnu AA; Kraus JF; Fanti C
    Trop Geogr Med; 1982; 34(4):341-5. PubMed ID: 7168003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia.
    Pegelow CH; Colangelo L; Steinberg M; Wright EC; Smith J; Phillips G; Vichinsky E
    Am J Med; 1997 Feb; 102(2):171-7. PubMed ID: 9217567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke in Nigerian children with sickle cell disease.
    Fatunde OJ; Adamson FG; Ogunseyinde O; Sodeinde O; Familusi JB
    Afr J Med Med Sci; 2005 Jun; 34(2):157-60. PubMed ID: 16749340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity--does it occur in Nigerian children with sickle cell anemia.
    Akodu SO; Diaku-Akinwumi IN; Njokanma OF
    Pediatr Hematol Oncol; 2012 May; 29(4):358-64. PubMed ID: 22568799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs.
    Blinder MA; Vekeman F; Sasane M; Trahey A; Paley C; Duh MS
    Pediatr Blood Cancer; 2013 May; 60(5):828-35. PubMed ID: 23335275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle cell disease clinical phenotypes in children from South-Western, Nigeria.
    Adegoke SA; Adeodu OO; Adekile AD
    Niger J Clin Pract; 2015; 18(1):95-101. PubMed ID: 25511352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central Nigeria.
    Ofakunrin AOD; Oguche S; Adekola K; Okpe ES; Afolaranmi TO; Diaku-Akinwumi IN; Zoakah AI; Sagay AS
    J Trop Pediatr; 2020 Jun; 66(3):290-298. PubMed ID: 31608959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomographic pattern of stroke in children with sickle cell anaemia in Ibadan.
    Ogunseyinde AO; Obajimi MO; Fatunde OJ
    Afr J Med Med Sci; 2005 Jun; 34(2):115-8. PubMed ID: 16749333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.